New therapeutics for the treatment of glycosphingolipid lysosomal storage diseases.

New therapeutics for the treatment of glycosphingolipid lysosomal storage diseases.

Glycosphingolipid lysosomal storage diseases are a small but challenging group of human disorders to treat. Although these appear to be monogenic disorders where the catalytic activity of enzymes in glycosphingolipid catabolism is impaired, the presentation and severity of disease is heterogeneous....

Podrobná bibliografie
Hlavní autoři:	Butters, T, Dwek, R, Platt, F
Médium:	Journal article
Jazyk:	English
Vydáno:	2003

Podobné jednotky

Glycosphingolipid lysosomal storage diseases: therapy and pathogenesis.
Autor: Jeyakumar, M, a další
Vydáno: (2002)

Inhibition of glycosphingolipid biosynthesis: application to lysosomal storage disorders.
Autor: Butters, T, a další
Vydáno: (2000)

Substrate deprivation: a new therapeutic approach for the glycosphingolipid lysosomal storage diseases.
Autor: Platt, F, a další
Vydáno: (2000)

New developments in treating glycosphingolipid storage diseases.
Autor: Platt, F, a další
Vydáno: (2005)

Glycosphingolipid profiling of tissues from mouse models of human lysosomal storage disorders
Autor: Priestman, D, a další
Vydáno: (2008)

Lysosomal storage of oligosaccharide and glycosphingolipid in imino sugar treated cells.
Autor: Boomkamp, S, a další
Vydáno: (2010)

Therapeutic applications of imino sugars in lysosomal storage disorders.
Autor: Butters, T, a další
Vydáno: (2003)

Impaired selection of invariant natural killer T cells in diverse mouse models of glycosphingolipid lysosomal storage diseases
Autor: Silk, J, a další
Vydáno: (2005)

Impaired selection of invariant natural killer T cells in diverse mouse models of glycosphingolipid lysosomal storage diseases.
Autor: Gadola, S, a další
Vydáno: (2006)

Small-molecule therapeutics for the treatment of glycolipid lysosomal storage disorders.
Autor: Butters, T, a další
Vydáno: (2003)

Storage solutions: treating lysosomal disorders of the brain.
Autor: Jeyakumar, M, a další
Vydáno: (2005)

N-butyldeoxygalactonojirimycin: a more selective inhibitor of glycosphingolipid biosynthesis than N-butyldeoxynojirimycin, in vitro and in vivo.
Autor: Andersson, U, a další
Vydáno: (2000)

Iminosugar inhibitors for treating the lysosomal glycosphingolipidoses
Autor: Butters, T, a další
Vydáno: (2005)

Imino sugar inhibitors for treating the lysosomal glycosphingolipidoses.
Autor: Butters, T, a další
Vydáno: (2005)

Cellular effects of deoxynojirimycin analogues: uptake, retention and inhibition of glycosphingolipid biosynthesis.
Autor: Mellor, H, a další
Vydáno: (2004)

Modulation of THP-1 macrophage and cholesterol-loaded foam cell apolipoprotein E levels by glycosphingolipids.
Autor: Garner, B, a další
Vydáno: (2002)

The development and use of small molecule inhibitors of glycosphingolipid metabolism for lysosomal storage diseases
Autor: James A. Shayman, a další
Vydáno: (2014-07-01)

Substrate reduction therapy for glycosphingolipid storage disorders.
Autor: Lachmann, R, a další
Vydáno: (2001)

Pharmacological impairment of acrosome formation and sperm head morphogenesis reveals essential role of glycosphingolipids in spermiogenesis
Autor: van der Spoel, A, a další
Vydáno: (2002)

Glycosphingolipid dysregulation and lysosomal dysfunction in motor neuron disease
Autor: da Silva Santos, CS
Vydáno: (2021)

ALTERED AUTOPHAGY AND APP METABOLISM IN GLYCOSPHINGOLIPID STORAGE DISEASES
Autor: Boland, B, a další
Vydáno: (2011)

Molecular requirements of imino sugars for the selective control of N-linked glycosylation and glycosphingolipid biosynthesis
Autor: Butters, T, a další
Vydáno: (2000)

Changes in glycosphingolipid levels in plasma and cerebrospinal fluid of individuals with Lysosomal Free Sialic Acid Storage Disorder
Autor: Marya S. Sabir, a další
Vydáno: (2025-01-01)

Glycosphingolipid disorders of the brain.
Autor: Boomkamp, S, a další
Vydáno: (2008)

Lysosomal dysfunction and glycosphingolipid dysregulation in rare and common neurodegenerative diseases
Autor: Huebecker, M
Vydáno: (2019)

Introduction: Glycosphingolipids in cell biology and disease.
Autor: Sillence, D, a další
Vydáno: (2004)

Analysis of fluorescently labeled glycosphingolipid-derived oligosaccharides following ceramide glycanase digestion and anthranilic acid labeling.
Autor: Neville, D, a další
Vydáno: (2004)

Lysosomal storage diseases
Autor: Platt, F, a další
Vydáno: (2018)

Glycosphingolipids and Infection. Potential New Therapeutic Avenues
Autor: Johannes M. F. G. Aerts, a další
Vydáno: (2019-12-01)

Lysosomal Ca(2+) homeostasis: role in pathogenesis of lysosomal storage diseases.
Autor: Lloyd-Evans, E, a další
Vydáno: (2011)

Accumulation of glycosphingolipids in Niemann-Pick C disease disrupts endosomal transport.
Autor: te Vruchte, D, a další
Vydáno: (2004)

Glycosphingolipid storage leads to the enhanced degradation of the B cell receptor in Sandhoff disease mice.
Autor: te Vruchte, D, a další
Vydáno: (2010)

Inhibition of substrate synthesis as a strategy for glycolipid lysosomal storage disease therapy.
Autor: Platt, F, a další
Vydáno: (2001)

Increased glycosphingolipid levels in serum and aortae of apolipoprotein E gene knockout mice.
Autor: Garner, B, a další
Vydáno: (2002)

Emptying the stores: lysosomal diseases and therapeutic strategies
Autor: Platt, F
Vydáno: (2017)

Glycosphingolipids in endocytic membrane transport.
Autor: Sillence, D, a další
Vydáno: (2004)

Diverse endogenous antigens for mouse NKT cells: self-antigens that are not glycosphingolipids.
Autor: Pei, B, a další
Vydáno: (2011)

Pharmacotherapeutic strategies using small molecules for the treatment of glycolipid lysosomal storage disorders.
Autor: Butters, T
Vydáno: (2007)

Therapeutic Approaches in Lysosomal Storage Diseases
Autor: Carlos Fernández-Pereira, a další
Vydáno: (2021-11-01)

The apo E gene knockout mouse as a model to study the potential atherogenic properties of glycosphingolipids
Autor: Garner, B, a další
Vydáno: (2003)